Featured Articles

  1. The Story Behind The Fastest-Recruiting COVID-19 Clinical Trial In Operation Warp Speed History 7/17/2023

    Learn how Citeline Connect supported the fastest-recruiting trial in the operation’s history, delivering 6,432 randomizations (22% of target), over 50% within the minority population, in a record-setting 48 days.

  2. Highlights From The 2023 Trialscope Disclose EXTRA User Conference 7/17/2023

    Step into the realm of clinical trial transparency and innovation as authors delve into the highlights and key learnings from the 2023 Trialscope Disclose EXTRA User Conference.

  3. Decentralized Clinical Trials: Meeting Patients Where They're At 7/12/2023

    Discover how innovations in DCTs are removing barriers in clinical research and medicine development to improve patient participation.

  4. Trial Diversity Needs: How We Got Here & Where We're Headed 7/12/2023

    Learn how the representation of underserved populations in clinical trials can be improved with the help of patients, professionals, advocacy groups, and community organizations.

  5. Improving Diversity Data In Clinical Trial Benchmarking & Feasibility 6/15/2023

    Improving diversity representation in clinical trials relies on demographic data. Get a glimpse of the problems sponsors encounter when obtaining this data and how regulatory agencies are working to ensure its accessibility.

  6. 2022 Completed Trials: A Roller Coaster Ride For Industry Sponsors 6/15/2023

    Dive into this analysis to better understand why the clinical trials landscape has not returned to its pre-pandemic level of momentum.

  7. Gene, Cell, & RNA Therapy Landscape: Q1 2023 Data Report 5/18/2023

    Get insight from the 2023 first quarter gene, cell, and RNA therapies report composed by Citeline, in conjunction with the American Society of Gene & Cell Therapy (ASGCT).

  8. Reimagining The Future: One Chapter At A Time 5/11/2023

    Get a glimpse of how the pharmaceutical industry has emerged from the tumultuous episode of the COVID-19 pandemic, stronger and emboldened.

  9. Pharma R&D Annual Review 2023 Supplement: New Substances Launched In 2022 5/11/2023

    In a sequel to the Pharma R&D Report, the author explores drugs that brought something genuinely new to the world of medicine in 2022 — new active substances (NASs) with some kind of novelty — that just might change the story of patients’ lives.

  10. Cross-Border M&A: 10 Key Trends To Watch In 2023 4/17/2023

    Many observers believe deal volume will remain buoyant throughout 2023. The need for access to cash is expected to continue to drive M&A decision-making. Heightened regulatory scrutiny, supply chain weakness, and consolidation are a few of the trends to watch for the remainder of the year.